Wi-Fi Securities Limited is a cyber security company that aims to revolutionise the security of public access Wi-Fi. To realise this vision, the company is developing a unique patent-protected system called SpriteGuard™ which will protect you and your data from hackers by stopping you connecting to fake hotspots. The system is targeted towards the $550 bn worldwide hospitality industry and has the ability to expand to other large global markets like city-wide free Wi-Fi, airports and coffee shops. Moreover, Wi-Fi Securities Limited has a highly experienced Wi-Fi Securities management board that has a track record of delivering multi-million-pound projects from concept to successful commercial deployment.
days to go:
Extended
investment:
£1,014,708
Medic Bleep is a simple, secure and innovative patient-focused solution to communication challenges that healthcare professionals and the wider team in the UK National Health Service (NHS) face while going about their everyday work. It is saving each nurse & each junior doctor an estimated 48 minutes per shift. This coincides with the UK's Department of Health calling for a ban on pagers. If implemented across the NHS, it could free up the time to care for an estimated 11,000 nurses. To ensure data privacy and safety, the company allows communication to occur via the app. As a result of these safeguards and its user-friendly portal, the company's app has been downloaded 16,000 times by UK doctors and nurses. With the funds raised, the company will aim to solve looming technology gaps for over 30% of the NHS in the next 3 years and expand globally.
days to go:
Expired
investment:
£814,600
LONDCAP is a mobile app that uses Artificial Intelligence (AI) and machine learning to enhance a customer's credit profile and make borrowing more accessible. The company aims to enable credit cards access to customers without credit history or national insurance number. It also endeavours to facilitate loan and mortgage approvals via its app. LONDCAP provides a live exchange money service at inter-bank rates as an approved licensee under the Financial Conduct Authority (FCA) laws. It has a network of over 30,000 companies and over 40,000 investors as of March 2020. The company will use the investment to achieve 50,000 monthly active users, prepare the business for the Series A fundraising round, build its team across different specialities, and launch a comprehensive app on the App Store and Google Playstore in partnership with financial entities like IBAN, SWIFT and SEPA.
days to go:
Expired
investment:
£108,373
Graphene Composites is a nano-materials technology company that creates the strongest, lightest, most resilient material by combining aerogel, graphene, and other nano-materials. Founded in 2016, the company, in partnerships with US/Global defence/aerospace contractor, is one of the few graphene nanotechnology companies who are developing bulletproof graphene/aerogel armour. Moreover, it is also extending its GC Shield technology to military/police applications. Besides these, GC's technology can also be used to improve the strength and reliability of wind turbines.
days to go:
Expired
investment:
£597,360
The Noo aims to redefine the delivery space by facilitating the delivery of anything, anywhere, anytime from a single application. It argues that between February-April 2020, online food delivery weekly sales skyrocketed by 840% amidst a boom in e-commerce sales. The Noo points out that with every innovation in the name of convenience, people seem to expect more. It intends to deliver just that through its community platform allowing anyone to request anything at a price set by the requestor and finally, facilitate earning by simply owning a smartphone. The company also aspires to create a space where the local high street can compete with today's delivery giants. It will use the investment to enhance and launch its app, fund marketing campaigns, hire key personnel, and make The Noo visible across more cities.
days to go:
Expired
investment:
£149,388
EMERGEiQ is a cloud-based platform targeted towards Small and Medium Enterprises (SMEs) and large corporate organisations. The company plans on having an extensive suite of algorithms that simplifies Data Science (DS) and Artificial Intelligence (AI) at low cost, across all sectors. EMERGEiQ asserts that its analytics can help businesses improve operational productivity, cut costs, and eventually generate more revenue. It has worked with companies across a variety of sectors such as finance, medicine, stock market, and insurance. The company will use will 30% of the investment for R&D, 25% to purchase software and hardware to improve platform capabilities, 25% to market its new product line, 10% as working capital, and 10% as miscellaneous expenses.
days to go:
Expired
investment:
£150,000
GymBuddy is an online platform that enables consumers to find, book, and attend a gym location, services, or products offered and operated by fitness studios, gyms, trainers, venues, or other third parties. Users can easily, through filtered searches on the app, view descriptions, and contact information of specialists within the fitness industry such as personal trainers, nutritionists, and physiotherapists. The UK fitness industry alone is currently worth over £5 billion. Based on recent statistics, the average gym membership in the UK costs members £40 a month, which often ties them into lengthy contracts. The GymBuddy app will enter the Health & Fitness club sector as a multi-gym membership feature that gives users access to gyms and various fitness plans, without the need for bricks-and-mortar locations under its brand. The company is seeking an investment of £400,000 to expand its brand identity and bring more users to its ecosystem to generate profits.
days to go:
Expired
investment:
Withheld
Invisage is a cloud-based platform that helps asset managers optimise their performance and research costs by identifying the true value of investment research. The company asserts that Directive 2014/65/EU has led to the investment research market falling from $16.5 billion to $14 billion as managers look to reduce costs and increase value. Invisage asserts that its platform helps asset managers identify, objectively measure ‘value’ added by research, and consume only high-impact research. The company also offers a web-based research consolidation, valuation and attribution solution that gives a quantitative assessment of value added by research to client portfolios. Invisage will use the investment to enhance deep learning-based Natural Language Processing (NLP) models that detect the implicit ideas from research narrative, build partnerships with data providers and other solution providers, and market scale its sales function
days to go:
Expired
investment:
£75,000
MedicSpot is a healthcare company that is aiming to revolutionise healthcare delivery by combining the advantages of online and offline care. The company provides patients at designated hospitals with diagnostic tools like a stethoscope, oximeter, blood pressure monitor and thermometer which, in turn, is connected to the MedicSpot network. Onboard General Physicians (GPs) engage in live sessions with patients, guide them on how to use the tools, and perform a variety of diagnoses like listening to a patient’s heart and lungs, looking down their throat and into their ears, taking their blood pressure and oxygen readings, and measuring their body temperature. The company is also expanding into another subsidiary, Arc Health, which it claims will perform the aforementioned tasks with more efficiency and accuracy. The company will use the investment to increase the number of Medicspot clinics to 1,000, gain further NHS market share, launch a corporate business model and allow international pilots to take place.
days to go:
Expired
investment:
£1,048,396
EnXray are developing Low Energy X-ray (LEXR) technologies to sterilise equipment in commercial or research settings where low volume/high value therapeutic products, such as cancer vaccines and stem cell implants are being developed. Their aim is to reduce the need for third party providers and have the sterilisation process done on-site and on-demand with simple and safe equipment to reduce cost and save time for medical research organisations.
days to go:
Expired
investment:
£376,230
